Cargando…

Detection of Epstein Barr Nuclear Antigen-1 (EBNA-1), Early Antigen 1F, 2R (EA-1F, EA- 2R) along with Epstein–Barr virus Latent Membrane Protein 1 (LMP1) in Breast Cancer of Northern India: An Interim Analysis

INTRODUCTION: Worldwide, breast cancer (BC) is a prominent cause of death, with a disproportionately high incidence in developed countries. Epstein-Barr virus (EBV) infection has been reported in up to 90% of the world’s population. Although the exact link of EBV infection and breast carcinoma is no...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahi, Vanshika, Agarwal, Preeti, Qayoom, Sumaira, Kumar, Vijay, Tewari, Shikha, Raghuvanshi, Shivanjali, Singh, Uma Shankar, Goel, Madhu Mati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930963/
https://www.ncbi.nlm.nih.gov/pubmed/36444584
http://dx.doi.org/10.31557/APJCP.2022.23.11.3717
_version_ 1784889143610834944
author Shahi, Vanshika
Agarwal, Preeti
Qayoom, Sumaira
Kumar, Vijay
Tewari, Shikha
Raghuvanshi, Shivanjali
Singh, Uma Shankar
Goel, Madhu Mati
author_facet Shahi, Vanshika
Agarwal, Preeti
Qayoom, Sumaira
Kumar, Vijay
Tewari, Shikha
Raghuvanshi, Shivanjali
Singh, Uma Shankar
Goel, Madhu Mati
author_sort Shahi, Vanshika
collection PubMed
description INTRODUCTION: Worldwide, breast cancer (BC) is a prominent cause of death, with a disproportionately high incidence in developed countries. Epstein-Barr virus (EBV) infection has been reported in up to 90% of the world’s population. Although the exact link of EBV infection and breast carcinoma is not yet determined. The present study was carried out to assess the pathological correlation of EBV infection and BC in women from Northern India. METHODOLOGY: In this prospective observational study, 130 patients with histologically proven breast carcinoma were included. After detailed histology, the paraffin block with infiltrative tumor was selected for molecular analysis and further immunohistochemistry (IHC)– EBV PCR and Epstein–Barr virus latent membrane protein 1 (LMP1) IHC. RESULTS: Most of the patients were diagnosed with Infiltrating Ductal Carcinoma not otherwise specified (IDC-NOS), followed by Infiltrating Ductal Carcinoma + Ductal Carcinoma in situ (IDC + DCIS). The total of 25 tissues of breast carcinoma had positive EBV PCR results (19.23%). The co-relation between the molecular and immunohistochemical results was significant in 11/25 cases that showed immunoexpression for LMP1 by IHC. Sensitivity of 44% and specificity of 100% were observed for LMP1 IHC, having a PPV value of 100% and an NPV of 88%. No significant correlation was observed between age, tumor subtype, grade, stage with respect to EBV infection; however, there was a significant association with nodal metastasis with extra nodal extension in tumors that had EBV infection. CONCLUSION: The present study establishes an association between LMP1 and patients with EBV positive breast cancer. The authors suggest that additional multicentric studies be conducted to strengthen the reliability and generalizability of the observations of the current study.
format Online
Article
Text
id pubmed-9930963
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-99309632023-02-16 Detection of Epstein Barr Nuclear Antigen-1 (EBNA-1), Early Antigen 1F, 2R (EA-1F, EA- 2R) along with Epstein–Barr virus Latent Membrane Protein 1 (LMP1) in Breast Cancer of Northern India: An Interim Analysis Shahi, Vanshika Agarwal, Preeti Qayoom, Sumaira Kumar, Vijay Tewari, Shikha Raghuvanshi, Shivanjali Singh, Uma Shankar Goel, Madhu Mati Asian Pac J Cancer Prev Research Article INTRODUCTION: Worldwide, breast cancer (BC) is a prominent cause of death, with a disproportionately high incidence in developed countries. Epstein-Barr virus (EBV) infection has been reported in up to 90% of the world’s population. Although the exact link of EBV infection and breast carcinoma is not yet determined. The present study was carried out to assess the pathological correlation of EBV infection and BC in women from Northern India. METHODOLOGY: In this prospective observational study, 130 patients with histologically proven breast carcinoma were included. After detailed histology, the paraffin block with infiltrative tumor was selected for molecular analysis and further immunohistochemistry (IHC)– EBV PCR and Epstein–Barr virus latent membrane protein 1 (LMP1) IHC. RESULTS: Most of the patients were diagnosed with Infiltrating Ductal Carcinoma not otherwise specified (IDC-NOS), followed by Infiltrating Ductal Carcinoma + Ductal Carcinoma in situ (IDC + DCIS). The total of 25 tissues of breast carcinoma had positive EBV PCR results (19.23%). The co-relation between the molecular and immunohistochemical results was significant in 11/25 cases that showed immunoexpression for LMP1 by IHC. Sensitivity of 44% and specificity of 100% were observed for LMP1 IHC, having a PPV value of 100% and an NPV of 88%. No significant correlation was observed between age, tumor subtype, grade, stage with respect to EBV infection; however, there was a significant association with nodal metastasis with extra nodal extension in tumors that had EBV infection. CONCLUSION: The present study establishes an association between LMP1 and patients with EBV positive breast cancer. The authors suggest that additional multicentric studies be conducted to strengthen the reliability and generalizability of the observations of the current study. West Asia Organization for Cancer Prevention 2022-11 /pmc/articles/PMC9930963/ /pubmed/36444584 http://dx.doi.org/10.31557/APJCP.2022.23.11.3717 Text en https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License. https://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Research Article
Shahi, Vanshika
Agarwal, Preeti
Qayoom, Sumaira
Kumar, Vijay
Tewari, Shikha
Raghuvanshi, Shivanjali
Singh, Uma Shankar
Goel, Madhu Mati
Detection of Epstein Barr Nuclear Antigen-1 (EBNA-1), Early Antigen 1F, 2R (EA-1F, EA- 2R) along with Epstein–Barr virus Latent Membrane Protein 1 (LMP1) in Breast Cancer of Northern India: An Interim Analysis
title Detection of Epstein Barr Nuclear Antigen-1 (EBNA-1), Early Antigen 1F, 2R (EA-1F, EA- 2R) along with Epstein–Barr virus Latent Membrane Protein 1 (LMP1) in Breast Cancer of Northern India: An Interim Analysis
title_full Detection of Epstein Barr Nuclear Antigen-1 (EBNA-1), Early Antigen 1F, 2R (EA-1F, EA- 2R) along with Epstein–Barr virus Latent Membrane Protein 1 (LMP1) in Breast Cancer of Northern India: An Interim Analysis
title_fullStr Detection of Epstein Barr Nuclear Antigen-1 (EBNA-1), Early Antigen 1F, 2R (EA-1F, EA- 2R) along with Epstein–Barr virus Latent Membrane Protein 1 (LMP1) in Breast Cancer of Northern India: An Interim Analysis
title_full_unstemmed Detection of Epstein Barr Nuclear Antigen-1 (EBNA-1), Early Antigen 1F, 2R (EA-1F, EA- 2R) along with Epstein–Barr virus Latent Membrane Protein 1 (LMP1) in Breast Cancer of Northern India: An Interim Analysis
title_short Detection of Epstein Barr Nuclear Antigen-1 (EBNA-1), Early Antigen 1F, 2R (EA-1F, EA- 2R) along with Epstein–Barr virus Latent Membrane Protein 1 (LMP1) in Breast Cancer of Northern India: An Interim Analysis
title_sort detection of epstein barr nuclear antigen-1 (ebna-1), early antigen 1f, 2r (ea-1f, ea- 2r) along with epstein–barr virus latent membrane protein 1 (lmp1) in breast cancer of northern india: an interim analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930963/
https://www.ncbi.nlm.nih.gov/pubmed/36444584
http://dx.doi.org/10.31557/APJCP.2022.23.11.3717
work_keys_str_mv AT shahivanshika detectionofepsteinbarrnuclearantigen1ebna1earlyantigen1f2rea1fea2ralongwithepsteinbarrviruslatentmembraneprotein1lmp1inbreastcancerofnorthernindiaaninterimanalysis
AT agarwalpreeti detectionofepsteinbarrnuclearantigen1ebna1earlyantigen1f2rea1fea2ralongwithepsteinbarrviruslatentmembraneprotein1lmp1inbreastcancerofnorthernindiaaninterimanalysis
AT qayoomsumaira detectionofepsteinbarrnuclearantigen1ebna1earlyantigen1f2rea1fea2ralongwithepsteinbarrviruslatentmembraneprotein1lmp1inbreastcancerofnorthernindiaaninterimanalysis
AT kumarvijay detectionofepsteinbarrnuclearantigen1ebna1earlyantigen1f2rea1fea2ralongwithepsteinbarrviruslatentmembraneprotein1lmp1inbreastcancerofnorthernindiaaninterimanalysis
AT tewarishikha detectionofepsteinbarrnuclearantigen1ebna1earlyantigen1f2rea1fea2ralongwithepsteinbarrviruslatentmembraneprotein1lmp1inbreastcancerofnorthernindiaaninterimanalysis
AT raghuvanshishivanjali detectionofepsteinbarrnuclearantigen1ebna1earlyantigen1f2rea1fea2ralongwithepsteinbarrviruslatentmembraneprotein1lmp1inbreastcancerofnorthernindiaaninterimanalysis
AT singhumashankar detectionofepsteinbarrnuclearantigen1ebna1earlyantigen1f2rea1fea2ralongwithepsteinbarrviruslatentmembraneprotein1lmp1inbreastcancerofnorthernindiaaninterimanalysis
AT goelmadhumati detectionofepsteinbarrnuclearantigen1ebna1earlyantigen1f2rea1fea2ralongwithepsteinbarrviruslatentmembraneprotein1lmp1inbreastcancerofnorthernindiaaninterimanalysis